Log in

323990 Vaxcell-Bio Therapeutics KRX · South Korea

Vaxcell-Bio Therapeutics (323990) news

Vaxcell-Bio Therapeutics is a public biotech or pharmaceutical company listed on KRX under the ticker 323990, recorded under South Korea. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Vaxcell-Bio Therapeutics news

We have not published a story on Vaxcell-Bio Therapeutics yet. When there is news, it will appear here.

Questions about Vaxcell-Bio Therapeutics

What is the ticker symbol of Vaxcell-Bio Therapeutics?

Vaxcell-Bio Therapeutics trades under the ticker 323990 on KRX.

Where is Vaxcell-Bio Therapeutics listed?

Vaxcell-Bio Therapeutics is listed on KRX.

Which country or territory is Vaxcell-Bio Therapeutics listed under?

Our directory records Vaxcell-Bio Therapeutics under South Korea.

What does Vaxcell-Bio Therapeutics do?

Our directory classifies Vaxcell-Bio Therapeutics as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Vaxcell-Bio Therapeutics?

The ISIN recorded for Vaxcell-Bio Therapeutics is KR7323990002.

Does aibio.space cover Vaxcell-Bio Therapeutics?

aibio.space lists Vaxcell-Bio Therapeutics among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Vaxcell-Bio Therapeutics?

Companies in our directory listed in the same country and business area as Vaxcell-Bio Therapeutics: CHOOLIP & SCIENCES, GC CELL CORPORATION, Epi Biotech Co., Rokit Healthcare, ImmuneOncia Therapeutics, Adbiotech Co..

Investor discussion: Vaxcell-Bio Therapeutics

Members talk about Vaxcell-Bio Therapeutics (323990). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open KRX:323990 on TradingView.

Listing details

Vaxcell-Bio Therapeutics is a public biotech or pharmaceutical company listed on KRX under the ticker 323990, recorded under South Korea. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Vaxcell-Bio Therapeutics
Ticker
323990
Listing
KRX
Country or territory
South Korea
Business scope
Biotechnology
ISIN
KR7323990002
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.